Avacta AVCTF Stock
Avacta Price Chart
Avacta AVCTF Financial and Trading Overview
| Avacta stock price | 1 USD |
| Previous Close | 1 USD |
| Open | 1 USD |
| Bid | 0.96 USD x 500000 |
| Ask | 1.04 USD x 10000 |
| Day's Range | 1 - 1 USD |
| 52 Week Range | 0.4 - 1.23 USD |
| Volume | 10K USD |
| Avg. Volume | 11.56K USD |
| Market Cap | 455.11M USD |
| Beta (5Y Monthly) | -0.1 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AVCTF Valuation Measures
| Enterprise Value | 419.45M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4027.5244 |
| Price/Book (mrq) | 123.86968 |
| Enterprise Value/Revenue | 3711.915 |
| Enterprise Value/EBITDA | -14.569 |
Trading Information
Avacta Stock Price History
| Beta (5Y Monthly) | -0.1 |
| 52-Week Change | 149.31% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 1.23 USD |
| 52 Week Low | 0.4 USD |
| 50-Day Moving Average | 0.97 USD |
| 200-Day Moving Average | 0.91 USD |
AVCTF Share Statistics
| Avg. Volume (3 month) | 11.56K USD |
| Avg. Daily Volume (10-Days) | 66.75K USD |
| Shares Outstanding | 455.11M |
| Float | 392.17M |
| Short Ratio | N/A |
| % Held by Insiders | 1.21% |
| % Held by Institutions | 7.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -30075.43% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.64% |
| Return on Equity (ttm) | -630.41% |
Income Statement
| Revenue (ttm) | 113K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 113K USD |
| EBITDA | -28791000 USD |
| Net Income Avi to Common (ttm) | -37059000 USD |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.86M USD |
| Total Cash Per Share (mrq) | 0.04 USD |
| Total Debt (mrq) | 17.71M USD |
| Total Debt/Equity (mrq) | 715.07 USD |
| Current Ratio (mrq) | 0.887 |
| Book Value Per Share (mrq) | 0.008073 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -24751000 USD |
| Levered Free Cash Flow (ttm) | -5863500 USD |
Profile of Avacta
| Country | United States |
| State | N/A |
| City | London |
| Address | Scale Space White City Imperial College Campus |
| ZIP | W12 7RZ |
| Phone | 44 203 9110353 |
| Website | https://avacta.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.
Q&A For Avacta Stock
What is a current AVCTF stock price?
Avacta AVCTF stock price today per share is 1 USD.
How to purchase Avacta stock?
You can buy AVCTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avacta?
The stock symbol or ticker of Avacta is AVCTF.
Which industry does the Avacta company belong to?
The Avacta industry is Biotechnology.
How many shares does Avacta have in circulation?
The max supply of Avacta shares is 455.11M.
What is Avacta Price to Earnings Ratio (PE Ratio)?
Avacta PE Ratio is now.
What was Avacta earnings per share over the trailing 12 months (TTM)?
Avacta EPS is -0.12 USD over the trailing 12 months.
Which sector does the Avacta company belong to?
The Avacta sector is Healthcare.